Pomerantz Law Firm Investigates Certara Over Potential Securities Fraud

EarningsManagement
โดย GlobeNewswire·Read original
Summary · why it matters

Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. The investigation concerns whether Certara and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. On May 11, 2026, Certara reported first quarter 2026 financial results, disclosing a 4% year-over-year decline in services revenue to $57.2 million and a 14% decline in services bookings to $66.6 million, while also announcing an exit from the regulatory business in its service segment. Following this news, Certara’s stock price fell $1.18 per share, or approximately 19%, to close at $5.13 on May 11, 2026. Then, on June 17, 2026, the company announced that Chief Financial Officer John Gallagher had notified Certara of his intent to resign effective July 14, 2026, after which the stock price fell $0.49 per share, or 8.13%, to close at $5.54 on June 18, 2026.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
Certara Inc
CERT
▼ NegativeCapitalrelevance

Certara reported declining services revenue and bookings, and announced exit from regulatory business, causing a 19% stock drop; CFO resignation further pressured stock.